ATC Group: J01FA01 Erythromycin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01FA01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01F Macrolides, lincosamides and streptogramins
4 J01FA Macrolides
5 J01FA01 Erythromycin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 1 g

Active ingredients in J01FA01

Active Ingredient Description
Erythromycin

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism.

Related product monographs

Title Information Source Document Type  
ERMYCIN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
ERY-TAB Delayed-release tablet FDA, National Drug Code (US) MPI, US: SPL/Old
ERYTHROCIN Film coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ERYTHROMYCIN Granules for oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ERYTHROMYCIN Powder for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ERYTHROPED SF Granules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PORPHYROCIN Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Australia (AU)

Brazil (BR)

Estonia (EE)

Finland (FI)

Japan (JP)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.